|
gptkbp:instance_of
|
gptkb:mythological_figure
|
|
gptkbp:affects
|
gptkb:Person
gptkb:mythological_figure
|
|
gptkbp:agent
|
gptkb:battle
|
|
gptkbp:associated_with
|
gptkb:biological_warfare
agriculture
|
|
gptkbp:casualties
|
up to 45% with treatment
up to 85% without treatment
|
|
gptkbp:caused_by
|
gptkb:Bacillus_anthracis
|
|
gptkbp:complications
|
meningitis
septicemia
pulmonary edema
|
|
gptkbp:conservation_status
|
spores can survive for years
|
|
gptkbp:disease_resistance
|
gptkb:ciprofloxacin
gptkb:penicillin
doxycycline
|
|
gptkbp:distribution
|
worldwide
|
|
gptkbp:duration
|
at least 60 days
|
|
gptkbp:end_of_life
|
high without treatment
lower with treatment
|
|
gptkbp:first_described_by
|
gptkb:2001_anthrax_attacks
|
|
gptkbp:healthcare
|
gptkb:battle
emergency preparedness
surveillance
response planning
|
|
gptkbp:historical_significance
|
used in research
used in warfare
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
inhalation anthrax
|
|
gptkbp:incubation_period
|
1 to 7 days
|
|
gptkbp:instrument
|
PCR testing
serology testing
culture of bacteria
|
|
gptkbp:is_protected_by
|
gptkb:motorcycle
vaccination
|
|
gptkbp:is_vulnerable_to
|
gptkb:battle
gptkb:anthrax_vaccine_adsorbed_(AVA)
|
|
gptkbp:number_of_teams
|
rapid
|
|
gptkbp:risk_factor
|
occupational exposure
bioterrorism
|
|
gptkbp:social_responsibility
|
gptkb:zoo
rare
CT scan
blood tests
chest X-ray
|
|
gptkbp:symptoms
|
cough
fever
shortness of breath
chest discomfort
flu-like symptoms
malaise
|
|
gptkbp:transmission
|
inhalation of spores
|
|
gptkbp:treatment
|
antibiotics
depends on timing
antitoxin
|
|
gptkbp:bfsParent
|
gptkb:mythological_figure
|
|
gptkbp:bfsLayer
|
3
|